Fresenius Kabi SwissBioSim GmbH et al. vs Regeneron Pharmaceuticals, Inc. - IPR2025-01268

Explore the PTAB proceeding IPR2025-01268 filed by Fresenius Kabi SwissBioSim GmbH et al. against Regeneron Pharmaceuticals, Inc. on Jul 14, 2025. This includes filing dates, application numbers, tech centers, patent numbers, and current case status.

Case Details

Proceeding Number
IPR2025-01268
Filing Date
Jul 14, 2025
Petitioner
Fresenius Kabi SwissBioSim GmbH et al.
Respondent
Regeneron Pharmaceuticals, Inc.
Status
Pending
Respondent Application Number
16739559
Respondent Tech Center
1600
Respondent Patent Number
11084865

Proceeding Decision New

Decision documents related to this case provide insights into the outcomes of proceedings. These documents are crucial for understanding the legal determinations and implications for the parties involved.

Proceeding Documents

The table below shows documents filed in the case, listing each document name, filing date, document type, and filing party. Tracking these filings indicates the activity of the parties involved in the case, and the types of documents filed can provide insights into the legal strategies being employed.

Document NameFiling DateCategoryFiling Party

Alert me when new update on this case

Patent Owner's Discretionary Denial Brief

Sep 23, 2025PAPERPATENT OWNER

Mylan Redacted Trial Decision, 22-cv-61, Dkt. 692 (N.D.W. Va.)

Sep 23, 2025EXHIBITPATENT OWNER

SB Redacted PI Decision, 24-md-3103, Dkt. 194 (N.D.W. Va.)

Sep 23, 2025EXHIBITPATENT OWNER

Formycon Redacted PI Decision, 24-md-3103, Dkt. 247 (N.D.W. Va.)

Sep 23, 2025EXHIBITPATENT OWNER

Celltrion Redacted PI Decision, 24-md-3103, Dkt. 248 (N.D.W. Va.)

Sep 23, 2025EXHIBITPATENT OWNER

SB Appeal Decision, 24-1965, Dkt. 76 (Fed. Cir.)

Sep 23, 2025EXHIBITPATENT OWNER

Formycon Appeal Decision, 24-2009, Dkt. 67 (Fed. Cir.)

Sep 23, 2025EXHIBITPATENT OWNER

Celltrion Appeal Decision, 24-2058, Dkt. 62 (Fed. Cir.)

Sep 23, 2025EXHIBITPATENT OWNER

Fresenius, Fresenius to Expand Biopharma Portfolio with a New Licensing Agreement to Commercialize a Proposed Aflibercept Biosimilar (Dec. 20, 2024), https://www.fresenius.com/node/6982

Sep 23, 2025EXHIBITPATENT OWNER

Email from D. Berl to S. Gibson re Scheduling Conference (Sept. 12, 2025)

Sep 23, 2025EXHIBITPATENT OWNER

Notice: Power of Attorney

Aug 4, 2025PAPERPATENT OWNER

Notice: Mandatory Notice

Aug 4, 2025PAPERPATENT OWNER

Notice: Notice filing date accorded

Jul 23, 2025PAPERBOARD

Petitioner Fresenius Kabi SwissBiosim, GmBH Power of Attorney

Jul 14, 2025PAPERPETITIONER

Fresenius Kabi SwissBiosim, GmBH Petition for IPR of USP11,084,865

Jul 14, 2025PAPERPETITIONER

Ex. 1001

Jul 14, 2025EXHIBITPETITIONER

Ex. 1002

Jul 14, 2025EXHIBITPETITIONER

Ex. 1003

Jul 14, 2025EXHIBITPETITIONER

Ex. 1004

Jul 14, 2025EXHIBITPETITIONER

Ex. 1005

Jul 14, 2025EXHIBITPETITIONER

Ex. 1006

Jul 14, 2025EXHIBITPETITIONER

Ex. 1007

Jul 14, 2025EXHIBITPETITIONER

Ex. 1008

Jul 14, 2025EXHIBITPETITIONER